Literature DB >> 11300634

Use of Erbium:YAG laser in the treatment of palpebral xanthelasmas.

G Mannino1, A Papale, F De Bella, R Mollo, P Morgia, C B Gabrieli.   

Abstract

OBJECTIVE: In light of the research and the use of lasers in the therapy of xanthelasmas, the authors report their experience in the treatment of this pathology with Erbium:YAG laser.
MATERIALS AND METHODS: In 30 patients, all female, 70 xanthelasmas were treated with Erbium:YAG laser, 65 (93%) of which were on the upper eyelid and 5 (7%) on the lower eyelid, varying from 1 x 1.5 mm to 11 X 20 mm in size. Spots with a diameter of 1.6 mm, energy of 300 mJ, frequency of 1-5 Hz and in a number varying were used in relation to the extent of the pathology.
RESULTS: In all cases, the appearance and functional results were good, without leaving scars and/or dyschromia.
CONCLUSIONS: Erbium:YAG laser, in the treatment of xanthelasmas, is a parasurgical method that is simple to perform and because of the successful aesthetic and functional results, is a valid alternative to the more traditional treatment methods.

Entities:  

Mesh:

Year:  2001        PMID: 11300634

Source DB:  PubMed          Journal:  Ophthalmic Surg Lasers        ISSN: 1082-3069


  4 in total

1.  Xanthelasma Palpebrarum: More than Meets the Eye.

Authors:  Shailesh Khode; Soon Heng Terry Tan; En-Pei Amanda Tan; Sandeep Uppal
Journal:  Indian J Otolaryngol Head Neck Surg       Date:  2018-04-07

2.  Argon laser versus erbium:YAG laser in the treatment of xanthelasma palpebrarum.

Authors:  Mona Abdelkader; Shereen Ezzelregal Alashry
Journal:  Saudi J Ophthalmol       Date:  2014-11-20

Review 3.  Xanthelasma: An Update on Treatment Modalities.

Authors:  Zainab Laftah; Firas Al-Niaimi
Journal:  J Cutan Aesthet Surg       Date:  2018 Jan-Mar

4.  Xanthelasma Palpebrarum with Arcus Cornea: A Clinical and Biochemical Study.

Authors:  Pragya Ashok Nair; Chaitali R Patel; Jaishree D Ganjiwale; Nilofar Gulamsha Diwan; Nidhi Bhimjibhai Jivani
Journal:  Indian J Dermatol       Date:  2016 May-Jun       Impact factor: 1.494

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.